International Conference on Drug Discovery and Development in Cancer Epigenetics ICDDDCE on November 29-30, 2022 in Bangkok, Thailand
Submit Your Paper
- Short Name: ICDDDCE
- Event Type: Conference
- Website URL: https://waset.org/drug-discovery-and-development-in-cancer-epigenetics-conference-in-november-2022-in-bangkok
- Program URL: https://waset.org/conferences-in-november-2022-in-bangkok/program
- Contact URL: https://waset.org
- Location: Bangkok, Thailand
- Date: November 29-30, 2022
- Final Submission: October 28, 2022
- Notification: December 15, 2020
- Organization: World Academy of Science, Engineering and Technology
- Conference Tags: drug drug discovery epigenetics drug development
Drug discovery in cancer epigenetics
Epigenetic mechanisms and phenomena
Cancer epigenetics
Methods and tools for epigenetic drug development
Drug discovery methods
Preclinical cancer models and clinical response
Discovery of biomarkers for drug development
Networks and consortia for epigenetic drug discovery
Classes of epigenetic drugs
DNA Methyltransferase Inhibitors
Small molecule inhibitors of Histone Deacetylases and Acetyltransferases
The development of selective methyltransferase and demethylase inhibitors
Bromodomains as anti-cancer targets
Epigenetic readers interpreting the Lysine Methylome
Non coding RNAs: clinical and therapeutic applications
Clinical implications of epigenetic therapy
Clinical applications of epigenetic drugs
Efficacy of combined epigenetic therapies
Predicting and monitoring responses to epigenetic drugs
Episensitization
The emerging potential for epigenetic therapeutics in non-cancer disorders
Epigenetic mechanisms and phenomena
Cancer epigenetics
Methods and tools for epigenetic drug development
Drug discovery methods
Preclinical cancer models and clinical response
Discovery of biomarkers for drug development
Networks and consortia for epigenetic drug discovery
Classes of epigenetic drugs
DNA Methyltransferase Inhibitors
Small molecule inhibitors of Histone Deacetylases and Acetyltransferases
The development of selective methyltransferase and demethylase inhibitors
Bromodomains as anti-cancer targets
Epigenetic readers interpreting the Lysine Methylome
Non coding RNAs: clinical and therapeutic applications
Clinical implications of epigenetic therapy
Clinical applications of epigenetic drugs
Efficacy of combined epigenetic therapies
Predicting and monitoring responses to epigenetic drugs
Episensitization
The emerging potential for epigenetic therapeutics in non-cancer disorders
Name: World Academy of Science, Engineering and Technology
Website: https://waset.org/
Address: UAE